News
Germany’s BionNTech SE is laying off workers in Cambridge as part of a broader move to make "targeted adjustments to our U.S.
A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...
While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, ...
A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising ...
BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2025 on Monday, August 4, 2025. Additionally, the Company will host a conference call ...
Explore more
A recent Turkish study published in Ophthalmic Epidemiology suggests the Pfizer-BioNTech COVID-19 vaccine may cause subtle ...
2d
The New Times on MSNIVI Africa’s Ndembi on Rwanda’s role in vaccine innovation and health securityA Cabinet meeting chaired by President Paul Kagame on June 9th, 2025, approved Prof. Nicaise Ndembi, Deputy Director General of the International Vaccine Institute (IVI), as the IVI Regional Director ...
Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.
Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results